The deal size was increased to $225M from $150M and priced below last closing price of $19.80. Jefferies, Goldman Sachs, Stifel and RBC Capital are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRDN:
- Closing Bell Movers: Dave & Busters jumps 10% after earnings beat
- Viridian Therapeutics announces $150M common stock and preferred stock offering
- Viridian Therapeutics price target raised to $40 from $33 at Stifel
- Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz
- Viridian TED data adds new overhang to Amgen’s Tepezza growth, says Barclays